# Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)

> **NCT06513065** · PHASE3 · RECRUITING · sponsor: **University of Southampton** · enrollment: 176 (estimated)

## Conditions studied

- Pseudomyxoma Peritonei

## Interventions

- **DRUG:** Mitomycin c

## Key facts

- **NCT ID:** NCT06513065
- **Lead sponsor:** University of Southampton
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-04
- **Primary completion:** 2028-09
- **Final completion:** 2029-04
- **Target enrollment:** 176 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06513065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06513065, "Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06513065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*